CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FiercePharma
Original article

{"a":[{"_":"Cellares downsizes New Jersey operations after losing BMS cell therapy contract","$":{"href":"/pharma/cellares-restructuring-rolls-new-jersey-amid-cell-therapy-client-loss","hreflang":"en"}}]}

Negative
AI Analysis

Summary

Cellares is downsizing its New Jersey operations after losing Bristol Myers Squibb as a client, as part of a right-sizing initiative announced by its CEO.

Importance:3/10
Sentiment:
-0.70
restructuringcontract_losscell_therapyoperations
Related Companies

Read the original article

Published by FiercePharma on September 2, 2026 9:12 AM

Read Original